BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4316110)

  • 21. [Problems of renovascular hypertension. Report on a international symposium on April 21-22, 1967 in Titisee-Schwarzwald].
    Kaufmann W; Klaus D; Nieth H; Schubert G; Thiel G
    Arzneimittelforschung; 1967 Aug; 17(8):1065-77. PubMed ID: 4299567
    [No Abstract]   [Full Text] [Related]  

  • 22. Renin, sodium-retaining and sodium-excreting hormones and experimental renal hypertension.
    Davis JO; Howards SS; Johnston CI; Wright FS
    Circ Res; 1967 Jul; 21(1):Suppl 2:167+. PubMed ID: 5599095
    [No Abstract]   [Full Text] [Related]  

  • 23. [Physiopathologic significance of binephrectomy in arterial hypertension].
    Meyer P
    Rev Fr Etud Clin Biol; 1969 Apr; 14(4):343-5. PubMed ID: 4308636
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma renin activity during development of experimental renal hypertension in dogs.
    Basso N; de la Riva IJ; Taquini AC
    Acta Physiol Lat Am; 1974; 24(5):563-8. PubMed ID: 4377509
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of sodium intake on physiological responses to angiotensin II in conscious dogs.
    Olsen ME; Meydrech EF
    Scand J Urol Nephrol Suppl; 1984; 79():29-34. PubMed ID: 6089315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on the pathogenesis and therapy of experimental hypertension in rats. I. Blood pressure, water balance, electrolyte excretion].
    Hilse H; Scheer E
    Acta Biol Med Ger; 1966; 17(4):451-63. PubMed ID: 5983628
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic functions of angiotensin in hypertension: renal effects as the basic cause of chronic hypertension.
    Guyton AC; Cowley AW; Fagard R; Langford HG; McCaa RE; DeClue JW; Coleman TG; Barnes GE
    Acta Physiol Lat Am; 1974; 24(5):592-5. PubMed ID: 4377512
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of inferior vena cava constriction on plasma renin concentration and on Na-K ratio in urine].
    Géral JP
    J Physiol (Paris); 1972; 64(2):107-14. PubMed ID: 4344777
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma renin activity during development of experimental antiserum glomerular nephritis.
    Fukuda M; Greene JA; Vander AJ
    J Lab Clin Med; 1968 Jan; 71(1):148-52. PubMed ID: 5635003
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of the renin--angiotensin system in experimental renal hypertension in dogs.
    Johnson JA; Davis JO; Spielman WS; Freeman RH
    Proc Soc Exp Biol Med; 1974 Nov; 147(2):387-91. PubMed ID: 4373756
    [No Abstract]   [Full Text] [Related]  

  • 32. The renin-angiotensin system and its relation with the electrolyte balance in experimental hypertension.
    Puchlev A; Somova L; Dochev D
    C R Acad Bulg Sci; 1969; 22(3):353-6. PubMed ID: 4307529
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of angiotensin. Indirect studies with antiangiotensin plasma.
    Worcel M; Meyer P; d' Auriac GA; Papanicolaou N; Milliez P
    Circ Res; 1970 Oct; 27():Suppl 2:223+. PubMed ID: 4319096
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of the kidney in experimental renovascular hypertension.
    Blair-West JR; Catt KJ; Cain MC; Denton DA; Funder JW; Nelson JF; Scoggins BA; Wright RD; Coghlan JP
    Circ Res; 1970 Oct; 27():Suppl 2:149+. PubMed ID: 4319092
    [No Abstract]   [Full Text] [Related]  

  • 36. [The significance of the dose and hypertension in realizing the renal effect of angiotensin].
    Branchevskiĭ LL
    Biull Eksp Biol Med; 1973 May; 75(5):53-5. PubMed ID: 4360361
    [No Abstract]   [Full Text] [Related]  

  • 37. Relationship between blood pressure and renin, angiotensin II and atrial natriuretic factor after renal transplantation.
    Hestin D; Mertes PM; Hubert J; Claudon M; Mejat E; Renoult E; Pertek JP; Frimat L; Burlet C; Kessler M
    Clin Nephrol; 1997 Aug; 48(2):98-103. PubMed ID: 9285146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental, acute renal hypertension and exogenous angiotensin II administration following premedication with the prostaglandin biosynthesis inhibitor indometacin].
    Schölkens BA
    Verh Dtsch Ges Inn Med; 1974; 80():285-8. PubMed ID: 4375905
    [No Abstract]   [Full Text] [Related]  

  • 39. Application of the renin-antirenin assay in experimental hypertension: a preliminary report.
    Keutel HJ; Outzen HC; Weaver RG
    Invest Urol; 1967 Sep; 5(2):107-14. PubMed ID: 4293227
    [No Abstract]   [Full Text] [Related]  

  • 40. Can angiotensin II cause renal hypertension when its plasma concentration is normal?
    Brown JJ; Cuesta V; Davies DL; Lever AF; Morton JJ; Padfield PL; Robertson JI; Trust P; Bianchi G; Schalekamp MA
    Contrib Nephrol; 1977; 8():57-60. PubMed ID: 891218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.